These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 14677970)

  • 1. Synthetic enantiopure aziridinomitosenes: preparation, reactivity, and DNA alkylation studies.
    Vedejs E; Naidu BN; Klapars A; Warner DL; Li VS; Na Y; Kohn H
    J Am Chem Soc; 2003 Dec; 125(51):15796-806. PubMed ID: 14677970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-silyl protecting groups for labile aziridines: application toward the synthesis of N-H aziridinomitosenes.
    Warner DL; Hibberd AM; Kalman M; Klapars A; Vedejs E
    J Org Chem; 2007 Oct; 72(22):8519-22. PubMed ID: 17910500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal azomethine ylide cycloaddition methodology for access to the substitution pattern of aziridinomitosene A.
    Bobeck DR; Warner DL; Vedejs E
    J Org Chem; 2007 Oct; 72(22):8506-18. PubMed ID: 17910499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of the aziridinomitosene skeleton by intramolecular Michael addition of alpha-lithioaziridines: an aromatic route featuring deuterium as a removable blocking group.
    Vedejs E; Little JD
    J Org Chem; 2004 Mar; 69(6):1794-9. PubMed ID: 15058920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aziridinomitosenes by anionic cyclization: deuterium as a removable blocking group.
    Vedejs E; Little J
    J Am Chem Soc; 2002 Feb; 124(5):748-9. PubMed ID: 11817939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic approach toward the proposed tetracyclic aziridinomitosene derived from FK317.
    Kim M; Vedejs E
    J Org Chem; 2004 Oct; 69(21):7262-5. PubMed ID: 15471479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxazolium-derived azomethine ylides. External oxazole activation and internal dipole trapping in the synthesis of an aziridinomitosene.
    Vedejs E; Piotrowski DW; Tucci FC
    J Org Chem; 2000 Sep; 65(18):5498-505. PubMed ID: 10970287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry and DNA alkylation reactions of aziridinyl quinones: development of an efficient alkylating agent of the phosphate backbone.
    Skibo EB; Xing C
    Biochemistry; 1998 Oct; 37(43):15199-213. PubMed ID: 9790684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectively N-protected enantiopure 2,5-disubstituted piperazines: avoiding the pitfalls in solid-phase Fukuyama-Mitsunobu cyclizations.
    Ottesen LK; Olsen CA; Witt M; Jaroszewski JW; Franzyk H
    Chemistry; 2009; 15(12):2966-78. PubMed ID: 19191236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and antitumor activity of 7-substituted 1,2-aziridinomitosenes.
    Iyengar BS; Remers WA; Bradner WT
    J Med Chem; 1986 Oct; 29(10):1864-8. PubMed ID: 3761307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enantio- and diastereoselective catalytic alkylation reactions with aziridines.
    Moss TA; Fenwick DR; Dixon DJ
    J Am Chem Soc; 2008 Aug; 130(31):10076-7. PubMed ID: 18616245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective synthesis of cis- and trans-2-(methyl/phenyl)-3-(trifluoromethyl)aziridines and their regio- and stereospecific ring opening.
    Moens M; De Kimpe N; D'hooghe M
    J Org Chem; 2014 Jun; 79(12):5558-68. PubMed ID: 24845942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reaction of reductively activated mitomycin C with aqueous bicarbonate: Isolation and characterization of an oxazolidinone derivative of cis-1-hydroxy-2,7-diaminomitosene.
    Paz MM
    Bioorg Med Chem Lett; 2010 Jan; 20(1):31-4. PubMed ID: 19954979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organolithium-induced alkylative ring opening of aziridines: synthesis of unsaturated amino alcohols and ethers.
    Hodgson DM; Stefane B; Miles TJ; Witherington J
    J Org Chem; 2006 Oct; 71(22):8510-5. PubMed ID: 17064027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-N,7'-N'-(1",2"-Dithianyl-3",6"-dimethylenyl)bismitomycin C: synthesis and nucleophilic activation of a dimeric mitomycin.
    Lee SH; Kohn H
    Org Biomol Chem; 2005 Feb; 3(3):471-82. PubMed ID: 15678185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemistry of the pyrrolo[1,2-alpha]benzimidazole antitumor agents: influence of the 7-substituent on the ability to alkylate DNA and inhibit topoisomerase II.
    Zhou R; Skibo EB
    J Med Chem; 1996 Oct; 39(21):4321-31. PubMed ID: 8863809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitomycin synthetic studies: stereocontrolled and convergent synthesis of a fully elaborated aziridinomitosane.
    Coleman RS; Felpin FX; Chen W
    J Org Chem; 2004 Oct; 69(21):7309-16. PubMed ID: 15471485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductive alkylation of beta-alkoxy aziridines: new route to substituted allylic amines.
    Rosser CM; Coote SC; Kirby JP; O'Brien P; Caine D
    Org Lett; 2004 Dec; 6(26):4817-9. PubMed ID: 15606074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of a flexible enantiospecific approach to aziridines.
    Jamookeeah CE; Beadle CD; Jackson RF; Harrity JP
    J Org Chem; 2008 Feb; 73(3):1128-30. PubMed ID: 18179238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial preparation of enantiopure unactivated aziridine-2-carboxamides and their transformation into enantiopure nonnatural amino acids and vic-diamines.
    Moran-Ramallal R; Liz R; Gotor V
    Org Lett; 2007 Feb; 9(3):521-4. PubMed ID: 17249802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.